Literature DB >> 7939774

Factor VIII inhibitor treatment. Economics of inhibitor treatment in Canada.

G E Rivard1, S Vick.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7939774

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  2 in total

1.  Determinants of drug costs in hopitalised patients with haemophilia: impact of recombinant activated factor VII.

Authors:  Jean Philippe Galanaud; Nathalie Pelletier-Fleury; Hélène Logerot-Lebrun; Thierry Lambert
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

2.  Cost-of-illness study of severe haemophilia A and B in five French haemophilia treatment centres.

Authors:  Virginie Nerich; Edgar Tissot; Albert Faradji; Karine Demesmay; Marie Anne Bertrand; Jean-Louis Lorenzini; Marie-Elisabeth Briquel; Patricia Pouzol; Marie-Christine Woronoff-Lemsi
Journal:  Pharm World Sci       Date:  2007-12-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.